Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 5427 citing articles:

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Circulation (2019) Vol. 139, Iss. 25
Open Access | Times Cited: 683
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Peter Rossing, Maria Luiza Caramori, Juliana C.N. Chan, et al.
Kidney International (2022) Vol. 102, Iss. 5, pp. S1-S127
Open Access | Times Cited: 681
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Tom G. Richardson, Eleanor Sanderson, Tom Palmer, et al.
PLoS Medicine (2020) Vol. 17, Iss. 3, pp. e1003062-e1003062
Open Access | Times Cited: 653
Statin Toxicity
Natalie C. Ward, Gerald F. Watts, Robert H. Eckel
Circulation Research (2019) Vol. 124, Iss. 2, pp. 328-350
Open Access | Times Cited: 596
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association
Samar R. El Khoudary, Brooke Aggarwal, Theresa M. Beckie, et al.
Circulation (2020) Vol. 142, Iss. 25
Open Access | Times Cited: 595
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Salim S. Virani, L. Kristin Newby, Suzanne V. Arnold, et al.
Circulation (2023) Vol. 148, Iss. 9
Open Access | Times Cited: 531
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg, Chris J. Packard, M. John Chapman, et al.
European Heart Journal (2021) Vol. 42, Iss. 47, pp. 4791-4806
Open Access | Times Cited: 524
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
Steven E. Nissen, A. Michael Lincoff, Danielle M. Brennan, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 15, pp. 1353-1364
Closed Access | Times Cited: 503
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
Matthew J. Feinstein, Priscilla Y. Hsue, Laura Benjamin, et al.
Circulation (2019) Vol. 140, Iss. 2
Open Access | Times Cited: 488
Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association
Michael H. Criqui, Kunihiro Matsushita, Victor Aboyans, et al.
Circulation (2021) Vol. 144, Iss. 9
Open Access | Times Cited: 477
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association
Gissette Reyes‐Soffer, Henry N. Ginsberg, Lars Berglund, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 42, Iss. 1
Open Access | Times Cited: 455
Worldwide Prevalence of Familial Hypercholesterolemia
Sabina Beheshti, Christian M. Madsen, Anette Varbo, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 20, pp. 2553-2566
Open Access | Times Cited: 436
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology
Donald M. Lloyd‐Jones, Lynne T. Braun, Chiadi E Ndumele, et al.
Circulation (2019) Vol. 139, Iss. 25
Open Access | Times Cited: 435
Primary prevention of cardiovascular disease: A review of contemporary guidance and literature
Jack Stewart, Gavin Manmathan, P M Wilkinson
JRSM Cardiovascular Disease (2017) Vol. 6
Open Access | Times Cited: 432
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
Don P. Wilson, Terry A. Jacobson, Peter H. Jones, et al.
Journal of clinical lipidology (2019) Vol. 13, Iss. 3, pp. 374-392
Closed Access | Times Cited: 424
Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association
Nisha I. Parikh, Juan M. González, Cheryl A.M. Anderson, et al.
Circulation (2021) Vol. 143, Iss. 18
Open Access | Times Cited: 422
Clinical review on triglycerides
Ulrich Laufs, Klaus G. Parhofer, Henry N. Ginsberg, et al.
European Heart Journal (2019) Vol. 41, Iss. 1, pp. 99-109c
Open Access | Times Cited: 415
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019

Diabetes Care (2018) Vol. 42, Iss. Supplement_1, pp. S103-S123
Open Access | Times Cited: 415
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease
Anne C. Goldberg, Lawrence A. Leiter, Erik S.G. Stroes, et al.
JAMA (2019) Vol. 322, Iss. 18, pp. 1780-1780
Open Access | Times Cited: 390
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
Ann C. Skulas‐Ray, Peter W.F. Wilson, William S. Harris, et al.
Circulation (2019) Vol. 140, Iss. 12
Open Access | Times Cited: 386
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Vera Bittner, Michael Szarek, Philip E. Aylward, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 2, pp. 133-144
Open Access | Times Cited: 383
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers
Nina Mars, Jukka Koskela, Pietari Ripatti, et al.
Nature Medicine (2020) Vol. 26, Iss. 4, pp. 549-557
Closed Access | Times Cited: 380
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
Maureen Sampson, Clarence Ling, Qian Sun, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 5, pp. 540-540
Open Access | Times Cited: 376
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities
Craig A. Elmets, Craig L. Leonardi, Dawn Marie R. Davis, et al.
Journal of the American Academy of Dermatology (2019) Vol. 80, Iss. 4, pp. 1073-1113
Closed Access | Times Cited: 375
Statin therapy increases lipoprotein(a) levels
Sotirios Tsimikas, Philip L.S.M. Gordts, Chelsea Nora, et al.
European Heart Journal (2019) Vol. 41, Iss. 24, pp. 2275-2284
Closed Access | Times Cited: 372

Scroll to top